Home » Topics » BioWorld Science

BioWorld Science
RSS

RegenxBio begins first-in-human study with RGX-121 gene therapy for Hunter's syndrome

July 16, 2018

FDA approves Xtandi for nonmetastatic castration-resistant prostate cancer

July 16, 2018

Researchers find a relationship between prediabetes and overactive bladder

July 16, 2018

FDA approves first drug to treat smallpox

July 16, 2018

Atossa Genetics initiates phase II study of endoxifen in neoadjuvant breast cancer

July 16, 2018

GlaxoSmithKline presents NRF2 activators

July 16, 2018

University of Nebraska identifies NF-kappaB activation inhibitors

July 16, 2018

OBI Pharma initiates phase I study of OBI-888 in patients with solid tumors

July 16, 2018

Idenix and Merck & Co. disclose anti-HIV-1 compounds

July 16, 2018

Janssen patents OGA inhibitors

July 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...